drug · small molecule
MR-107A02
pre_registrationupdated 3mo agoby $VTRS Viatris Inc🔗 ChEMBL
community read0 votes
🐶 often sniffed alongside
top 8- drugmeloxicam SR2 co-mentions · 2 sources
- tagRecall2 co-mentions · 2 sources
- drugcyclobenzaprine hydrochloride2 co-mentions · 1 sources
- drugCyclobenzaprine Hydrochloride Teva2 co-mentions · 1 sources
- drugmeloxicam2 co-mentions · 2 sources
- drugcyclobenzaprine hydrochloride ER2 co-mentions · 1 sources
- companyUnichem Pharmaceuticals (USA) Inc1 co-mentions · 1 sources
- companyUnichem Laboratories Ltd1 co-mentions · 1 sources
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 14 investigational indications.
targets
Prostaglandin G/H synthase 2
all catalysts(0)
nothing on the calendar yet
Trials studying MR-107A02
- phase3Initiating Early Control of Migraine Pain and Associated Symptoms
- phase3Open-Label Study of AXS-07 for the Acute Treatment of Migraine in Adults With a Prior Inadequate Response to an Oral CGRP Inhibitor (EMERGE)
- phase3Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-severe Pain Following Abdominal Surgery
- phase1Safety, Tolerability and Pharmacokinetics of Meloxicam Nanocrystal Injection in Healthy Subjects
- phase3Efficacy and Safety of Injectable Association of Dexamethasone, Dipyrone and Hydrocobalamin in Lumbar Sciatic Pain
- phase1Meloxicam 15 mg Tablets Under Fasting Conditions
- phase1Meloxicam 15 mg Tablets Under Non-Fasting Conditions
- phase1Food Study of Meloxicam Tablets 15 mg and Mobic® Tablets 15 mg
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 12m ago
Found something off?
comments(0)
5-min edit window · permanent after that